- Home
- NPCE vs TKNO Comparison
NPCE vs TKNO Comparison
Compare NPCE & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCE
- TKNO
- Stock Information
- Founded
- NPCE 1997
- TKNO 1996
- Country
- NPCE United States
- TKNO United States
- Employees
- NPCE N/A
- TKNO N/A
- Industry
- NPCE Medical Specialities
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- NPCE Health Care
- TKNO Health Care
- Exchange
- NPCE Nasdaq
- TKNO Nasdaq
- Market Cap
- NPCE 292.9M
- TKNO 256.9M
- IPO Year
- NPCE 2021
- TKNO 2021
- Fundamental
- Price
- NPCE $8.56
- TKNO $4.69
- Analyst Decision
- NPCE Strong Buy
- TKNO
- Analyst Count
- NPCE 6
- TKNO 0
- Target Price
- NPCE $16.67
- TKNO N/A
- AVG Volume (30 Days)
- NPCE 205.8K
- TKNO 325.8K
- Earning Date
- NPCE 08-12-2025
- TKNO 08-07-2025
- Dividend Yield
- NPCE N/A
- TKNO N/A
- EPS Growth
- NPCE N/A
- TKNO N/A
- EPS
- NPCE N/A
- TKNO N/A
- Revenue
- NPCE $88,570,000.00
- TKNO $38,923,000.00
- Revenue This Year
- NPCE $21.04
- TKNO $8.73
- Revenue Next Year
- NPCE $10.73
- TKNO $16.53
- P/E Ratio
- NPCE N/A
- TKNO N/A
- Revenue Growth
- NPCE 23.32
- TKNO 11.40
- 52 Week Low
- NPCE $5.45
- TKNO $3.75
- 52 Week High
- NPCE $18.98
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- NPCE 36.80
- TKNO 49.37
- Support Level
- NPCE $7.56
- TKNO $4.39
- Resistance Level
- NPCE $9.68
- TKNO $4.97
- Average True Range (ATR)
- NPCE 0.56
- TKNO 0.42
- MACD
- NPCE 0.09
- TKNO 0.06
- Stochastic Oscillator
- NPCE 47.12
- TKNO 45.52
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.